Cargando…

Editorial: The Mechanisms of Action of Anti-SARS-CoV-2 Drugs

Detalles Bibliográficos
Autores principales:	Zhong, Wu, Brancaleone, Vincenzo, Sultana, Janet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013936/ https://www.ncbi.nlm.nih.gov/pubmed/35444535 http://dx.doi.org/10.3389/fphar.2022.894310

Ejemplares similares

Corrigendum: Editorial: The mechanisms of action of anti-SARS-CoV-2 drugs
por: Zhong, Wu, et al.
Publicado: (2022)

Editorial: Interplays and Functions of Gaseous Mediators: From Underlying Mechanisms to Therapeutic Approaches in Cardiovascular Diseases
por: Brancaleone, Vincenzo, et al.
Publicado: (2022)

Mechanism of Action of Small-Molecule Agents in Ongoing Clinical Trials for SARS-CoV-2: A Review
por: Zhao, Lei, et al.
Publicado: (2022)

Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)
por: Verma, Surjeet, et al.
Publicado: (2020)

Editorial: Role of Blood Cells in Inflammatory and Vascular Disorders
por: Brancaleone, Vincenzo, et al.
Publicado: (2020)

Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology
por: Pala, Daniele, et al.
Publicado: (2021)

Anti–SARS-CoV-2 Natural Products as Potentially Therapeutic Agents
por: Kim, Cheorl-Ho
Publicado: (2021)

Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing
por: Kern, Charlotte, et al.
Publicado: (2021)

Editorial: Cell cycle control as a new therapeutic approach for SARS-CoV-2 infection
por: Rizzo, Roberta, et al.
Publicado: (2023)

Editorial: Action and Mechanism of Herbal Glycans
por: Li, Shaoping, et al.
Publicado: (2022)

Molecular Mechanisms of Action of Emodin: As an Anti-Cardiovascular Disease Drug
por: Li, Qianqian, et al.
Publicado: (2020)

Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
por: Chen, Catherine Z., et al.
Publicado: (2021)

Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development
por: Liu, Xiao-Huan, et al.
Publicado: (2022)

Marine Sponge is a Promising Natural Source of Anti-SARS-CoV-2 Scaffold
por: Hamoda, Alshaimaa M., et al.
Publicado: (2021)

Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitro
por: Xiong, Hua-Long, et al.
Publicado: (2021)

Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease
por: Pinzi, Luca, et al.
Publicado: (2021)

A report on SARS-CoV-2 first wave in Ecuador: drug consumption dynamics
por: Orellana-Manzano, Andrea, et al.
Publicado: (2023)

A review of SARS-CoV-2 drug repurposing: databases and machine learning models
por: Elkashlan, Marim, et al.
Publicado: (2023)

Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives
por: Yang, Cheng-Wei, et al.
Publicado: (2020)

Editorial: Gastrointestinal and Liver Effects of Fruits and Their Synergism With Drug Therapy: Exploring Possible Mechanisms of Action
por: Wanderley, Almir Gonçalves, et al.
Publicado: (2022)

Molecular Mechanisms Behind Anti SARS-CoV-2 Action of Lactoferrin
por: Miotto, Mattia, et al.
Publicado: (2021)

The Hyperlipidaemic Drug Fenofibrate Significantly Reduces Infection by SARS-CoV-2 in Cell Culture Models
por: Davies, Scott P., et al.
Publicado: (2021)

Drug targets, mechanisms of drug action, and therapeutics against SARS-CoV-2
por: Jena, N.R.
Publicado: (2021)

Editorial: Immunity in the development of anti-cancer drug resistance
por: Meng, Ya, et al.
Publicado: (2022)

An update on SARS-CoV-2 immunization and future directions
por: Rana, Rashmi, et al.
Publicado: (2023)

Low-Dose Fluvoxamine Modulates Endocytic Trafficking of SARS-CoV-2 Spike Protein: A Potential Mechanism for Anti-COVID-19 Protection by Antidepressants
por: Glebov, Oleg O.
Publicado: (2021)

Drug-related problems in patients admitted for SARS-CoV-2 infection during the COVID-19 pandemic
por: Barceló-Vidal, J., et al.
Publicado: (2022)

An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants
por: Tallei, Trina Ekawati, et al.
Publicado: (2021)

The Anti-Histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits Infection by Major Variants of SARS-CoV-2 in Cell Cultures and Reconstituted Human Nasal Tissue
por: Konrat, Robert, et al.
Publicado: (2022)

The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
por: Xia, Binbin, et al.
Publicado: (2023)

Mechanism of action of favipiravir against SARS-CoV-2: Mutagenesis or chain termination?
por: Zhao, Lei, et al.
Publicado: (2021)

Ugonin J Acts as a SARS-CoV-2 3C-like Protease Inhibitor and Exhibits Anti-inflammatory Properties
por: Chiou, Wei-Chung, et al.
Publicado: (2021)

Editorial: Pharmacological mechanisms of drugs affecting bone formation and bone resorption
por: Zhang, Dongwei, et al.
Publicado: (2023)

Single-cell sequencing of brain tissues reveal the central nervous system’s susceptibility to SARS-CoV-2 and the drug
por: Lu, Zhichao, et al.
Publicado: (2022)

An Evaluation of Traditional Persian Medicine for the Management of SARS-CoV-2
por: Bahramsoltani, Roodabeh, et al.
Publicado: (2020)

Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences
por: Campione, Elena, et al.
Publicado: (2021)

SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models
por: Kanimozhi, G., et al.
Publicado: (2021)

Discovery of New Potent anti-MERS CoV Fusion Inhibitors
por: Kandeel, Mahmoud, et al.
Publicado: (2021)

Editorial: Women in pharmacology of anti-cancer drugs: 2021
por: Giovannetti, Elisa
Publicado: (2022)

Editorial: Insights in pharmacology of anti‐cancer drugs: 2021
por: Sancho, Patricia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nfepuemtcl5kfigogl2e6gabfp